![]() |
Volumn 47, Issue 1, 2008, Pages 50-55
|
Baseline CD4 cell count and outcome of pegylated interferon plus ribavirin therapy in HIV/hepatitis C virus-coinfected patients
a,b,j
d
UNIV LILLE
(France)
|
Author keywords
Antiviral agents; Chronic; Cohort studies; Genotype; Hepatitis C; HIV infections
|
Indexed keywords
PEGINTERFERON;
PROTEINASE INHIBITOR;
RIBAVIRIN;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
VIRUS RNA;
ALPHA2A INTERFERON;
MACROGOL DERIVATIVE;
PEGINTERFERON ALFA-2A;
PEGINTERFERON ALPHA2A;
UNCLASSIFIED DRUG;
ADULT;
ARTICLE;
BLOOD TOXICITY;
CD4 LYMPHOCYTE COUNT;
CLINICAL TRIAL;
COHORT ANALYSIS;
CONFIDENCE INTERVAL;
CONTROLLED STUDY;
DRUG WITHDRAWAL;
FEMALE;
FOLLOW UP;
FRANCE;
GENOTYPE;
HEPATITIS C;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
MAJOR CLINICAL STUDY;
MALE;
MENTAL DISEASE;
MIXED INFECTION;
MULTICENTER STUDY;
PRIORITY JOURNAL;
PROBABILITY;
RETROSPECTIVE STUDY;
STATISTICAL SIGNIFICANCE;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
GENETICS;
HEPATITIS C VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS;
ISOLATION AND PURIFICATION;
VIRUS LOAD;
ADULT;
CD4 LYMPHOCYTE COUNT;
FEMALE;
HEPACIVIRUS;
HEPATITIS C;
HIV;
HIV INFECTIONS;
HUMANS;
INTERFERON ALFA-2A;
MALE;
POLYETHYLENE GLYCOLS;
RIBAVIRIN;
TREATMENT OUTCOME;
VIRAL LOAD;
|
EID: 39049129274
PISSN: 15254135
EISSN: None
Source Type: Journal
DOI: 10.1097/QAI.0b013e318157b0da Document Type: Article |
Times cited : (14)
|
References (27)
|